Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
Clinical trial NCT06439589 · UNKNOWN
Trial details
- NCT number
- NCT06439589
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2025-12-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.